The researchers say that statins, widely used to reduce cholesterol levels in many countries, are generally much less effective among southern Chinese populations. This study may indeed reveal genetic differences that account for this and could direct the development of new forms of cholesterol-lowering drugs that work better. This would be a prime example of population-level stratified medicine in action.